Portugal, July 6 -- Portugal based Biocartis NV has secured contract from Instituto Portugues De Oncologia Do Porto Francisco Gentil, Epe for Adcm 4756/25 Idh1-2 Mutation Assay [Test] . The value of the contract is worth 6300 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....